[{"notes_id":"1_1404","category":"11","subcategory":"1","title":"Progestogen only pill: advantages\/disadvantages","body":"Advantages<br \/><ul><li>highly effective (failure rate = 1 per 100 woman years)<\/li><li>doesn't interfere with sex<\/li><li>contraceptive effects reversible upon stopping<\/li><li>can be used whilst breast-feeding<\/li><li>can be used in situations where the combined oral contraceptive pill is contraindicated e.g. in smokers > 35 years of age and women with a history of venous thromboembolic disease<\/li><\/ul><br \/>Disadvantages<br \/><ul><li>irregular periods: some users may not have periods whilst others may have irregular or light periods. This is the most common adverse effect<\/li><li>doesn't protect against sexually transmitted infections<\/li><li>increased incidence of functional ovarian cysts<\/li><li>common side-effects include breast tenderness, weight gain, acne and headaches. These symptoms generally subside after the first few months<\/li><\/ul>","notes_hash":"bd89addc133adba3d26684de20156bca","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Healthcare<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1169\" data-linkid=\"1169\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1169\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">2<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1169\" data-linkid=\"1169\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1169\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/cec-ceu-guidance-pop-mar-2015\/\">2015 POP guidelines<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":[],"category_name":"Reproductive","subcategory_name":"Contraception","comment_count":1},"",[]]